Altre lingue Edwards Lifesciences Corporation London S.E.

Azioni

0REN

US28176E1082

Tempo differito London S.E. Altri mercati azionari 15:34:46 05/02/2021			Variaz. 5gg	Var. 1 gen.
77,56 ^CHF	+5,72%		-.--%	-.--%

17/06	EDWARDS LIFESCIENCES CORPORATION : prospettiva positiva di Wolfe Research	ZM
05/06	Edwards Lifesciences annuncia i risultati dell'analisi dei dati degli studi partner che esaminano gli esiti dei pazienti con sostituzione della valvola aortica transcatetere con un anulus piccolo	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	03/06
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03/06
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06
Edwards Lifesciences to Sell Critical Care to BD	03/06
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03/06
EE.UU. - Valores a seguir en Wall Street (actualizado)	31/05
Edwards Lifesciences : Charter of the Audit Committee	28/05
Some of the biggest splits in Corporate America	23/05
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	13/05
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13/05
Edwards Lifesciences hit with Meril's EU antitrust complaint	13/05
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	09/05
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

Edwards Lifesciences Corporation: la storia continua

23 aprile 2024 alle 15:14